New Zealand markets open in 2 hours 54 minutes

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
502.79+1.20 (+0.24%)
At close: 04:00PM EDT
502.60 -0.19 (-0.04%)
After hours: 07:37PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 193.59B
Enterprise value 224.46B
Trailing P/E 34.29
Forward P/E 20.12
PEG ratio (5-yr expected) 1.94
Price/sales (ttm)4.51
Price/book (mrq)4.42
Enterprise value/revenue 5.16
Enterprise value/EBITDA 21.10

Trading information

Stock price history

Beta (5Y monthly) 0.77
52-week change 3-2.47%
S&P500 52-week change 318.47%
52-week high 3609.85
52-week low 3475.77
50-day moving average 3538.42
200-day moving average 3547.10

Share statistics

Avg vol (3-month) 31.47M
Avg vol (10-day) 31.95M
Shares outstanding 5385.95M
Implied shares outstanding 6385.95M
Float 8385.16M
% held by insiders 10.19%
% held by institutions 191.80%
Shares short (30 Aug 2023) 42.61M
Short ratio (30 Aug 2023) 42.32
Short % of float (30 Aug 2023) 40.68%
Short % of shares outstanding (30 Aug 2023) 40.68%
Shares short (prior month 30 Jul 2023) 43.04M

Dividends & splits

Forward annual dividend rate 41.4
Forward annual dividend yield 40.28%
Trailing annual dividend rate 31.30
Trailing annual dividend yield 30.26%
5-year average dividend yield 40.22
Payout ratio 48.89%
Dividend date 312 Oct 2023
Ex-dividend date 413 Sept 2023
Last split factor 23:2
Last split date 305 Jun 1996

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Jun 2023


Profit margin 13.14%
Operating margin (ttm)16.62%

Management effectiveness

Return on assets (ttm)4.90%
Return on equity (ttm)13.26%

Income statement

Revenue (ttm)43.52B
Revenue per share (ttm)111.89
Quarterly revenue growth (yoy)-2.60%
Gross profit (ttm)19B
Net income avi to common (ttm)5.72B
Diluted EPS (ttm)14.65
Quarterly earnings growth (yoy)-18.20%

Balance sheet

Total cash (mrq)3.13B
Total cash per share (mrq)8.12
Total debt (mrq)34.02B
Total debt/equity (mrq)77.47%
Current ratio (mrq)1.42
Book value per share (mrq)113.36

Cash flow statement

Operating cash flow (ttm)7.69B
Levered free cash flow (ttm)4.39B